Home : Health : Cancer :

Photo

Cancer

7 questions on cancer gene testing

Angelina Jolie's case highlights the importance of knowing …

Angelina Jolie says she had double mastectomy

Angelina Jolie has double mastectomy

Angelina Jolie says that she has had a preventive double …

Grieving dad helps kids get to chemo

Richard Nares organizes free rides to the hospital for poor …

Docs blast ethics of $100K cancer drugs

A group of more than 120 cancer researchers and physicians took…

WNYers sought for new cancer study

A new cancer prevention study is underway, and the American …

FDA accepts Aveo kidney cancer pill application

Possible treatment for several cancer types

Updated: Wednesday, 28 Nov 2012, 5:04 PM EST
Published : Wednesday, 28 Nov 2012, 5:04 PM EST

The Associated Press

CAMBRIDGE, Mass. (AP) - Aveo Oncology said Wednesday that the Food and Drug Administration will complete a review of its cancer pill Tivopath by July 28.

Aveo and its partner Astellas Pharma Inc. want to market Tivopath as a treatment for advanced kidney cancer. The companies said the FDA accepted their application, and the agency will conduct a standard 10-month review. Astellas will pay Aveo $15 million now that the filing has been accepted.

Tivopath, or tivozanib, is a tablet intended to be taken once per day. The companies are also studying the drug as a treatment for other solid tumors, including cancers of the breast and colon.

Comments

With WIVB.com's new commenting system you don't need to register. You can login with an existing Facebook, Yahoo!, Google, or Twitter account and more. If you have a WIVB.com login you can still use it in our Participate section.